Diagram of a typical organ bath preparation. An excised piece of smooth muscle tissue is held in an oxygenated solution in a chamber. The tissue is attached to a lever, which transmits its contraction to a myograph, thus recording the physiological response. Drugs under investigation can be administered directly to the chamber
An organ chamber, organ bath (or, colloquially, gut bath) is a chamber in which isolated organs or tissues can be administered with drugs, or stimulated electrically, in order to measure their function. The tissue in the organ bath is typically oxygenated with carbogen and kept in a solution such as Tyrode's solution or lactated Ringer's solution.[citation needed]
For studying the effects of drugs on receptors in drug discovery and combinatorial chemistry, novel techniques such as high throughput screening, ultrahigh throughput screening and high content screening, pharmacogenomics,
proteomics and array technology have largely superseded the use of organ baths.[8] These techniques can allow more receptor specificity than organ bath preparations, as a single tissue sample can express many different receptor types.[citation needed]
The use of organ bath preparations for the measurement of physiological tissue responses to drug concentrations allows the generation of dose response curves. This in turn allows the quantification of a drug's pharmacological profile in the tissue in question, such as the calculation of the drug's EC50, IC50, and Hill coefficient.[citation needed]
Historical contributions
Examples of important contributions made using this technique include:
^Briejer, MR; Akkermans, LM; Schuurkes, JA (1995). "Interactions of serotonin with multiple receptors and neurotransmitters in the guinea-pig isolated colon". Archives Internationales de Pharmacodynamie et de Thérapie. 329 (1): 121–33. PMID7639614.
^Burnstock, G; Verkhratsky, A (March 2010). "Vas deferens--a model used to establish sympathetic cotransmission". Trends in Pharmacological Sciences. 31 (3): 131–9. doi:10.1016/j.tips.2009.12.002. PMID20074819.
^Fry, CH (2004). "Experimental models to study the physiology, pathophysiology, and pharmacology of the lower urinary tract". Journal of Pharmacological and Toxicological Methods. 49 (3): 201–10. doi:10.1016/j.vascn.2004.03.002. PMID15172016.
^Dong, Q; Deng, S; Wang, R; Yuan, J (February 2011). "In vitro and in vivo animal models in priapism research". The Journal of Sexual Medicine. 8 (2): 347–59. doi:10.1111/j.1743-6109.2010.02052.x. PMID20946160.
^ abLangton, Philip D. (2012). Essential Guide to Reading Biomedical Papers.
^Vogel, Hans (2008). Drug Discovery and Evaluation: Pharmacological Assays (3 ed.). pp. 9–10. ISBN978-3-540-70995-4.
^Bennett, Max R. (March 2000). "The concept of transmitter receptors: 100 years on". Neuropharmacology. 39 (4): 523–546. doi:10.1016/S0028-3908(99)00137-9.